Hims & Hers Health, Inc.
HIMSNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for HIMS. That does not mean none is planned.
Get an email about HIMS's next catalysts
Track Hims & Hers Health (HIMS) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model.
WebsiteNo drugs found in this phase.
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
When is Hims & Hers Health, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Hims & Hers Health, Inc. (HIMS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track HIMS biotech catalysts?→
Add HIMS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Hims & Hers Health, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.